George Dranitsaris

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

M. Lacouture, G. Dranitsaris, M. Vincent, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes Assessment of a Pharmacist-Directed Seamless Care Program in an Ambulatory Oncology Clinic

Michael LeBlanc, N. MacKinnon, G. Dranitsaris, 2014, Journal of pharmacy practice.

The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia

Tim Crook, G. Dranitsaris, T. Crook, 2010, European journal of haematology.

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine

M. Lacouture, G. Dranitsaris, George Dranitsaris, 2014, Breast Cancer Research and Treatment.

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.

Mark Clemons, Ian F Tannock, Andreas Laupacis, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.